What question did this study set out to answer?

This study aims to explore how quercetin influences liver inflammation and fibrosis in non-alcoholic fatty liver disease (NAFLD).

April 23, 2026MetabolitesOpen Access

Quercetin Attenuates Non-Alcoholic Fatty Liver Disease in Association with the Inhibition of Hepatic IL-1β/iNOS and IL-1β/CD45 Axes of Inflammation and Fibrosis Accompanied by Reduced Endogenous Metabolites and Apoptosis

View Full Paper

Ask AI

Bookmark

Authors

Animal model investigates quercetin's effects on liver inflammation and fibrosis in NAFLD, suggesting potential therapeutic benefits.

This study aims to explore how quercetin influences liver inflammation and fibrosis in non-alcoholic fatty liver disease (NAFLD).
Rats were fed a high-fat and high-carbohydrate diet for 4 weeks to induce NAFLD.
One group received quercetin alongside the diet for 4 weeks to assess protective effects.
Liver inflammation, fibrosis markers, and metabolic parameters were measured post-treatment.
NAFLD was confirmed with significant dyslipidemia, hyperglycemia, and liver injury enzyme elevation.
Quercetin treatment significantly reduced inflammation and fibrosis markers including IL-1β and iNOS.
A strong correlation was observed between IL-1β levels and hepatic injury parameters.

Alqahtani et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark